press release

Stivarga Approved to Treat GIST Patients in Japan

Stivarga has just been approved in Japan for the treatment of GIST. Keep reading for more information.Official Stivarga Press Release:Bayer HealthCare has received approval from the Japanese authorities (MHLW) for the marketing of Regorafenib (Stivarga) [...]

By |2019-09-20T12:04:14-04:00August 21st, 2013|Drug Treatment, News, Stivarga|

The GIST Cancer Journal – First Journal Specifically focused on GIST

The GIST Cancer Journal is the first journal specifically focused on Gastrointestinal Stromal Tumors (GIST).  Keep reading for more information.The GIST Cancer Journal Official Press Release:CONTACT/MEDIA INQUIRIES: Erin Kristoff, Marketing and Communications DirectorThe Life Raft GroupWayne Plaza [...]

By |2019-09-20T12:08:53-04:00August 20th, 2013|News|

Alianza GIST sets forth plan for strengthening the coalition in Latin America

Alianza GIST has set forth a plan to strengthen the coalition in Latin America. Keep reading for the official press release and more information about Alianza GIST.

By |2019-09-23T12:49:08-04:00August 15th, 2013|Advocacy, Global, News|

LRG responds to recent Cancer Cell coverage

Yesterday, there were a series of news stories reporting on an article published by Cooke et al inCancer Cell. Unfortunately, the coverage gave misleading information which could suggest that patients should not take Gleevec (imatinib) or Sutent (sunitinib).

By |2014-09-17T10:15:35-04:00January 19th, 2011|News|
Go to Top